                         SEQUENCE LISTING

<110>  UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
       THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY OF AGRICULTURE
       PEREZ, DANIEL R.
       RAJAO, DANIELA
       KEHRLI, MARCUS E.
       VINCENT, AMY L.
 
<120>  COMPOSITIONS AND METHODS OF USE THEREOF FOR PREVENTION AND 
       TREATMENT OF INFLUENZA INFECTIONS

<130>  UGA 2019-094-02 PCT

<150>  . 63/077,454
<151>  2020-09-11

<160>  31    

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  1

Asn Ser Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg Leu 
1               5                   10                  15      


Glu Phe Val Gln Tyr Gln Ser 
            20              


<210>  2
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  2

Lys Ser Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg Leu 
1               5                   10                  15      


Glu Phe Val Gln Tyr Gln Ser 
            20              


<210>  3
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  3

Asn Ser Pro Cys Gly Asn Gln Ala Thr Val Leu Cys Ile Ser Arg Leu 
1               5                   10                  15      


Glu Phe Val Gln Tyr Gln Ser 
            20              


<210>  4
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  4

Gly Asn Ser Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg 
1               5                   10                  15      


Leu Glu Phe Val Gln Tyr Gln Ser 
            20                  


<210>  5
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  5

Gly Lys Ser Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg 
1               5                   10                  15      


Leu Glu Phe Val Gln Tyr Gln Ser 
            20                  


<210>  6
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  6

Gly Asn Ser Pro Cys Gly Asn Gln Ala Thr Val Leu Cys Ile Ser Arg 
1               5                   10                  15      


Leu Glu Phe Val Gln Tyr Gln Ser 
            20                  


<210>  7
<211>  47
<212>  PRT
<213>  Bos taurus

<400>  7

Met Lys Lys Arg Ser Val Ser Gly Cys Asn Ile Thr Ile Leu Ala Val 
1               5                   10                  15      


Val Phe Ser His Leu Ser Ala Gly Asn Ser Pro Cys Gly Asn Gln Ala 
            20                  25                  30          


Asn Val Leu Cys Ile Ser Arg Leu Glu Phe Val Gln Tyr Gln Ser 
        35                  40                  45          


<210>  8
<211>  53
<212>  PRT
<213>  Homo sapiens

<400>  8

Met Cys Ser Tyr Tyr His Met Lys Lys Arg Ser Val Ser Gly Cys Asn 
1               5                   10                  15      


Ile Thr Ile Phe Ala Val Met Phe Ser His Leu Ser Ala Gly Lys Ser 
            20                  25                  30          


Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg Leu Glu Phe 
        35                  40                  45              


Val Gln Tyr Gln Ser 
    50              


<210>  9
<211>  47
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  9

Met Lys Lys Arg Ser Val Ser Gly Cys Asn Ile Thr Ile Phe Ala Val 
1               5                   10                  15      


Met Phe Ser His Leu Ser Ala Gly Lys Ser Pro Cys Gly Asn Gln Ala 
            20                  25                  30          


Asn Val Leu Cys Ile Ser Arg Leu Glu Phe Val Gln Tyr Gln Ser 
        35                  40                  45          


<210>  10
<211>  53
<212>  PRT
<213>  Mus musculus

<400>  10

Met Cys Ser Tyr Tyr His Met Lys Lys Arg Ser Val Leu Gly Cys Asn 
1               5                   10                  15      


Ile Thr Ile Phe Ala Val Met Phe Ser His Leu Ser Ala Gly Asn Ser 
            20                  25                  30          


Pro Cys Gly Asn Gln Ala Thr Val Leu Cys Ile Ser Arg Leu Glu Phe 
        35                  40                  45              


Val Gln Tyr Gln Ser 
    50              


<210>  11
<211>  47
<212>  PRT
<213>  Mus musculus

<400>  11

Met Lys Lys Arg Ser Val Leu Gly Cys Asn Ile Thr Ile Phe Ala Val 
1               5                   10                  15      


Met Phe Ser His Leu Ser Ala Gly Asn Ser Pro Cys Gly Asn Gln Ala 
            20                  25                  30          


Thr Val Leu Cys Ile Ser Arg Leu Glu Phe Val Gln Tyr Gln Ser 
        35                  40                  45          


<210>  12
<211>  53
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  12

Met Cys Ser Tyr Tyr His Met Lys Lys Arg Ser Val Ser Gly Cys Asn 
1               5                   10                  15      


Ile Thr Ile Leu Ala Val Met Phe Ser His Leu Ser Ala Gly Asn Ser 
            20                  25                  30          


Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg Leu Glu Phe 
        35                  40                  45              


Val Gln Tyr Gln Ser 
    50              


<210>  13
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X = any amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X = Lysine (K) or Arginine (R)

<400>  13

Arg Xaa Xaa Arg 
1               


<210>  14
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  14

Lys Arg Lys Arg Lys Lys Arg 
1               5           


<210>  15
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X = any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X = any amino acid

<400>  15

Asp Xaa Glu Xaa Asn Pro Gly Pro 
1               5               


<210>  16
<211>  18
<212>  PRT
<213>  Unknown

<220>
<223>  Thosea asigna virus

<400>  16

Glu Gly Arg Gly Ser Leu Leu Thr Cys Gly Asp Val Glu Glu Asn Pro 
1               5                   10                  15      


Gly Pro 
        


<210>  17
<211>  19
<212>  PRT
<213>  Unknown

<220>
<223>  porcine teschovirus-1

<400>  17

Ala Thr Asn Phe Ser Leu Leu Lys Gln Ala Gly Asp Val Glu Glu Asn 
1               5                   10                  15      


Pro Gly Pro 
            


<210>  18
<211>  20
<212>  PRT
<213>  Unknown

<220>
<223>  rhinitis A virus

<400>  18

Gln Cys Thr Asn Tyr Ala Leu Leu Lys Leu Ala Gly Asp Val Glu Ser 
1               5                   10                  15      


Asn Pro Gly Pro 
            20  


<210>  19
<211>  22
<212>  PRT
<213>  Foot-and-mouth disease virus

<400>  19

Val Lys Gln Thr Leu Asn Phe Asp Leu Leu Lys Leu Ala Gly Asp Val 
1               5                   10                  15      


Glu Ser Asn Pro Gly Pro 
            20          


<210>  20
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  20

Gly Ser Gly Ser 
1               


<210>  21
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  21

Gly Gly Gly Ser 
1               


<210>  22
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  22

Gly Gly Gly Gly Ser 
1               5   


<210>  23
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  23

Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10  


<210>  24
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  24

Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser 
            20  


<210>  25
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  25

Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  


<210>  26
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  26

Met Gly Val Lys Val Leu Phe Ala Leu Ile Cys Ile Ala Val Ala Glu 
1               5                   10                  15      


Ala 
    


<210>  27
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  27

Cys His Tyr Ser Glu Leu 
1               5       


<210>  28
<211>  74
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  28

Gly Asn Ser Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg 
1               5                   10                  15      


Leu Glu Phe Val Gln Tyr Gln Ser Gly Gly Gly Gly Ser Lys Arg Lys 
            20                  25                  30          


Arg Lys Lys Arg Gly Leu Phe Glu Gly Arg Gly Ser Leu Leu Thr Cys 
        35                  40                  45              


Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Val Lys Val Leu Phe 
    50                  55                  60                  


Ala Leu Ile Cys Ile Ala Val Ala Glu Ala 
65                  70                  


<210>  29
<211>  69
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  29

Lys Arg Lys Arg Lys Lys Arg Gly Leu Phe Glu Gly Arg Gly Ser Leu 
1               5                   10                  15      


Leu Thr Cys Gly Asp Val Glu Glu Asn Pro Gly Pro Met Gly Val Lys 
            20                  25                  30          


Val Leu Phe Ala Leu Ile Cys Ile Ala Val Ala Glu Ala Gly Asn Ser 
        35                  40                  45              


Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg Leu Glu Phe 
    50                  55                  60                  


Val Gln Tyr Gln Ser 
65                  


<210>  30
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  X = any amino acid

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  X = any amino acid

<400>  30

Xaa Glu Xaa Asp 
1               


<210>  31
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic polypeptide

<400>  31

Gly Asn Ser Pro Cys Gly Asn Gln Ala Asn Val Leu Cys Ile Ser Arg 
1               5                   10                  15      


Leu Glu Phe Val Gln Tyr Gln Ser Gly Gly Gly Gly Ser Lys Arg Lys 
            20                  25                  30          


Arg Lys Lys Arg 
        35      


